The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment
Open accessAbstract
Understanding the mechanisms of immune cell migration to multiple sclerosis lesions offers significant therapeutic potential. This study focused on the chemokines CXCL12 (SDF-1) and CXCL13 (BCA-1), both of which regulate B cell migration in lymphoid tissues. We report that immunohistologically CXCL12 was constitutively expressed in CNS parenchyma on blood vessel walls. In both active and chronic inactive multiple sclerosis lesions CXCL12 protein was elevated and detected on astrocytes and blood vessels. Quantitative PCR demonstrated that CXCL13 was produced in actively demyelinating multiple sclerosis lesions, but not in chronic inactive lesions or in the CNS of subjects who had no neurological disease. CXCL13 protein was localized in perivascular infiltrates and scattered infiltrating cells in lesion parenchyma. In the CSF of relapsing-remitting multiple sclerosis patients, both CXCL12 and CXCL13 were elevated. CXCL13, but not CXCL12, levels correlated strongly with intrathecal immunoglobulin production as well as the presence of B cells, plasma blasts and T cells. About 20% of CSF CD4+ cells and almost all B cells expressed the CXCL13 receptor CXCR5. In vitro, CXCL13 was produced by monocytes and at much higher levels by macrophages. CXCL13 mRNA and protein expression was induced by TNFalpha and IL-1beta but inhibited by IL-4 and IFNgamma. Together, CXCL12 and CXCL13 are elevated in active multiple sclerosis lesions and CXCL12 also in inactive lesions. The consequences of CXCL12 up-regulation could be manifold. CXCL12 localization on blood vessels indicates a possible role in leucocyte extravasation, and CXCL12 may contribute to plasma cell persistence since its receptor CXCR4 is retained during plasma cell differentiation. CXCL12 may contribute to axonal damage as it can become a neurotoxic mediator of cleavage by metalloproteases, which are present in multiple sclerosis lesions. The strong linkage of CXCL13 to immune cells and immunoglobulin levels in CSF suggests that this is one of the factors that attract and maintain B and T cells in inflamed CNS lesions. Therefore, both CXCL13 and CXCR5 may be promising therapeutic targets in multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600
Processing of gene expression data generated by quantitative real-time RT-PCR.
Muller, P. Y., Janovjak, H., Miserez, A. R., & Dobbie, Z. (2002) · PubMed · Cited by 1,394
A chemokine-driven positive feedback loop organizes lymphoid follicles
Ansel, K. M., Ngo, V. N., Hyman, P. L., Luther, S. A., Förster, R., Sedgwick, J. D., Browning, J. L., Lipp, M., & Cyster, J. G. (2000) · Nature · doi:10.1038/35018581 · Cited by 1,278
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Miller, D. H., Khan, O. A., Sheremata, W. A., Blumhardt, L. D., Rice, G. P. A., Libonati, M. A., Willmer-Hulme, A. J., Dalton, C. M., Miszkiel, K. A., & O'Connor, P. W. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020696 · Cited by 1,242
Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., & Aloisi, F. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00049.x · Cited by 1,208
Metalloproteinases in biology and pathology of the nervous system
Yong, V. W., Power, C., Forsyth, P., & Edwards, D. R. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081571 · Cited by 1,060
Three or more routes for leukocyte migration into the central nervous system
Ransohoff, R. M., Kivisäkk, P., & Kidd, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1130 · Cited by 1,052
Self-citationSørensen, T. L., Tani, M., Jensen, J., Pierce, V., Lucchinetti, C., Folcik, V. A., Qin, S., Rottman, J., Sellebjerg, F., Strieter, R. M., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5150 · Cited by 1,002
Self-citationBabbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M., Schröder, R., Deckert, M., Schmidt, S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.393 · Cited by 951
Self-citationBalashov, K. E., Rottman, J. B., Weiner, H. L., & Hancock, W. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6873 · Cited by 849
Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5
Allen, C. D. C., Ansel, K. M., Low, C., Lesley, R., Tamamura, H., Fujii, N., & Cyster, J. G. (2004) · Nature Immunology · doi:10.1038/ni1100 · Cited by 802
A Coordinated Change in Chemokine Responsiveness Guides Plasma Cell Movements
Hargreaves, D. C., Hyman, P. L., Lu, T. T., Ngo, V. N., Bidgol, A., Suzuki, G., Zou, Y.-R., Littman, D. R., & Cyster, J. G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.1.45 · Cited by 659
Subspecialization of Cxcr5+ T Cells
Kim, C. H., Rott, L. S., Clark-Lewis, I., Campbell, D. J., Wu, L., & Butcher, E. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.12.1373 · Cited by 625
Synthesis and release of B-lymphocyte stimulator from myeloid cells
Nardelli, B., Belvedere, O., Roschke, V., Moore, P. A., Olsen, H. S., Migone, T. S., Sosnovtseva, S., Carrell, J. A., Feng, P., Giri, J. G., et al. (2001) · Blood · doi:10.1182/blood.v97.1.198 · Cited by 576
Krumbholz, M., Theil, D., Derfuss, T., Rosenwald, A., Schrader, F., Monoranu, C.-M., Kalled, S. L., Hess, D. M., Serafini, B., Aloisi, F., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041674 · Cited by 492
Self-citationNanki, T., Hayashida, K., El-Gabalawy, H. S., Suson, S., Shi, K., Girschick, H. J., Yavuz, S., & Lipsky, P. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6590 · Cited by 455
Simpson, J. E., Newcombe, J., Cuzner, M. L., & Woodroofe, M. N. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00208-7 · Cited by 408
Self-citationHesselgesser, J., Taub, D., Baskar, P., Greenberg, M., Hoxie, J., Kolson, D. L., & Horuk, R. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70230-1 · Cited by 408
Hill, W. D., Hess, D. C., Martin-Studdard, A., Carothers, J. J., Zheng, J., Hale, D., Maeda, M., Fagan, S. C., Carroll, J. E., & Conway, S. J. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.1.84 · Cited by 403
Stumm, R. K., Rummel, J., Junker, V., Culmsee, C., Pfeiffer, M., Krieglstein, J., Höllt, V., & Schulz, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-14-05865.2002 · Cited by 391
Cepok, S., Rosche, B., Grummel, V., Vogel, F., Zhou, D., Sayn, J., Sommer, N., Hartung, H.-P., & Hemmer, B. (2005) · Brain · doi:10.1093/brain/awh486 · Cited by 367
Self-citationCorcione, A., Casazza, S., Ferretti, E., Giunti, D., Zappia, E., Pistorio, A., Gambini, C., Mancardi, G. L., Uccelli, A., & Pistoia, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402455101 · Cited by 349
Qin, Y., Duquette, P., Zhang, Y., Talbot, P., Poole, R., & Antel, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3568 · Cited by 320
Zhang, K., McQuibban, G. A., Silva, C., Butler, G. S., Johnston, J. B., Holden, J., Clark-Lewis, I., Overall, C. M., & Power, C. (2003) · Nature Neuroscience · doi:10.1038/nn1127 · Cited by 305
Mazzucchelli, L., Blaser, A., Kappeler, A., Schärli, P., Laissue, J. A., Baggiolini, M., & Uguccioni, M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7830 · Cited by 300
B Cell Repertoire Diversity and Clonal Expansion in Multiple Sclerosis Brain Lesions
Baranzini, S. E., Jeong, M. C., Butunoi, C., Murray, R. S., Bernard, C. C. A., & Oksenberg, J. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.5133 · Cited by 294
Lazarini, F., Tham, T. N., Casanova, P., Arenzana‐Seisdedos, F., & Dubois‐Dalcq, M. (2003) · Glia · doi:10.1002/glia.10139 · Cited by 280
Shi, K., Hayashida, K., Kaneko, M., Hashimoto, J., Tomita, T., Lipsky, P. E., Yoshikawa, H., & Ochi, T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.650 · Cited by 280
Expression of CCR7 in multiple sclerosis: implications for CNS immunity
Kivisäkk, P., Mahad, D. J., Callahan, M. K., Sikora, K., Trebst, C., Tucky, B., Wujek, J., Ravid, R., Staugaitis, S. M., Lassmann, H., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20049 · Cited by 267
Self-citationCarlsen, H. S., Baekkevold, E. S., Morton, H. C., Haraldsen, G., & Brandtzaeg, P. (2004) · Blood · doi:10.1182/blood-2004-02-0701 · Cited by 266
Hitchon, C., Wong, K., Ma, G., Reed, J., Lyttle, D., & El‐Gabalawy, H. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10520 · Cited by 248
Colombo, M., Dono, M., Gazzola, P., Roncella, S., Valetto, A., Chiorazzi, N., Mancardi, G. L., & Ferrarini, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2782 · Cited by 246
Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis
Cepok, S. (2001) · Brain · doi:10.1093/brain/124.11.2169 · Cited by 242
Self-citationTrebst, C., Lykke Sørensen, T., Kivisäkk, P., Cathcart, M. K., Hesselgesser, J., Horuk, R., Sellebjerg, F., Lassmann, H., & Ransohoff, R. M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63017-9 · Cited by 242
Self-citationStromal-Cell Derived Factor Is Expressed by Dendritic Cells and Endothelium in Human Skin
Pablos, J. L., Amara, A., Bouloc, A., Santiago, B., Caruz, A., Galindo, M., Delaunay, T., Virelizier, J. L., & Arenzana-Seisdedos, F. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65474-0 · Cited by 240
Chemokines, Chemokine Receptors, and Allograft Rejection
Nelson, P. J., & Krensky, A. M. (2001) · Immunity · doi:10.1016/s1074-7613(01)00118-2 · Cited by 234
Graumann, U., Reynolds, R., Steck, A. J., & Schaeren‐Wiemers, N. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00485.x · Cited by 233
Hypoxia-like tissue injury as a component of multiple sclerosis lesions
Lassmann, H. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00421-5 · Cited by 218
Simpson, J. E., Newcombe, J., Cuzner, M. L., & Woodroofe, M. N. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2000.026002133.x · Cited by 209
Self-citationOwens, G. P., Ritchie, A. M., Burgoon, M. P., Williamson, R. A., Corboy, J. R., & Gilden, D. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2725 · Cited by 209
Axonal Pathology in Multiple Sclerosis. A Historical Note
Kornek, B., & Lassmann, H. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00547.x · Cited by 197
Determinants of Human B Cell Migration Across Brain Endothelial Cells
Alter, A., Duddy, M., Hebert, S., Biernacki, K., Prat, A., Antel, J. P., Yong, V. W., Nuttall, R. K., Pennington, C. J., Edwards, D. R., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4497 · Cited by 195
Restricted use of VH4 Germline segments in an acute multiple sclerosis brain
Owens, G. P., Kannus, H., Burgoon, M. P., Smith‐Jensen, T., Devlin, M. E., & Gilden, D. H. (1998) · Annals of Neurology · doi:10.1002/ana.410430214 · Cited by 173
Salomonsson, S., Larsson, P., Tengnér, P., Mellquist, E., Hjelmström, P., & Wahren‐Herlenius, M. (2002) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2002.01058.x · Cited by 172
Walsh, M. J., & Tourtellotte, W. W. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.1.41 · Cited by 168
Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions
Ambrosini, E., Remoli, M. E., Giacomini, E., Rosicarelli, B., Serafini, B., Lande, R., Aloisi, F., & Coccia, E. M. (2005) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000173893.01929.fc · Cited by 161
The chemokine CXCL13 (BLC): A putative diagnostic marker for neuroborreliosis
Rupprecht, T. A., Pfister, H., Angele, B., Kastenbauer, S., Wilske, B., & Koedel, U. (2005) · Neurology · doi:10.1212/01.wnl.0000171349.06645.79 · Cited by 149
The Chemokine System in Neuroinflammation: An Update
Ransohoff, R. M. (2002) · The Journal of Infectious Diseases · doi:10.1086/344266 · Cited by 146
Self-citationKivisäkk, P., Trebst, C., Liu, Z., Tucky, B. H., Sørensen, T. L., Rudick, R. A., Mack, M., & Ransohoff, R. M. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01947.x · Cited by 145
Self-citationDavenport, H. (1947) · Journal of the London Mathematical Society · doi:10.1112/jlms/s1-22.2.100 · Cited by 140
TNF-α mediates SDF-1α–induced NF-κB activation and cytotoxic effects in primary astrocytes
Han, Y., He, T., Huang, D., Pardo, C. A., & Ransohoff, R. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12629 · Cited by 134
Self-citationImmune and nervous system CXCL12 and CXCR4: parallel roles in patterning and plasticity
Klein, R. S., & Rubin, J. B. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.04.002 · Cited by 132
The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis
Narayan, K., Dail, D., Li, L., Cadavid, D., Amrute, S. B., Fitzgerald-Bocarsly, P. A., & Pachner, A. R. (2005) · Annals of Neurology · doi:10.1002/ana.20486 · Cited by 128
Langenkamp, A., Nagata, K., Murphy, K. E., Wu, L., Lanzavecchia, A., & Sallusto, F. (2003) · European Journal of Immunology · doi:10.1002/immu.200310023 · Cited by 113
Unveiling the enigma of the CNS as a B-cell fostering environment
Uccelli, A., Aloisi, F., & Pistoia, V. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.02.009 · Cited by 91
Pashenkov, M. V., Söderström, M. B., & Link, H. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00441-1 · Cited by 83
Ritchie, A. M., Gilden, D. H., Williamson, R. A., Burgoon, M. P., Yu, X., Helm, K. M., Corboy, J. R., & Owens, G. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.649 · Cited by 78
Aust, G., Sittig, D. F., Becherer, L., Anderegg, U., Schutz, A., Lamesch, P., & Schmücking, E. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500225 · Cited by 73
Expression of stromal cell-derived factor 1α protein in HIV encephalitis
Langford, D., Sanders, V. J., Mallory, M. E., Kaul, M., & Masliah, E. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00068-1 · Cited by 59
A new paraclinical CSF marker for hypoxia‐like tissue damage in multiple sclerosis lesions
Lassmann, H., Reindl, M., Rauschka, H., Berger, J., Aboul‐Enein, F., Berger, T., Zurbriggen, A., Lutterotti, A., Brück, W., Weber, J. R., et al. (2003) · Brain · doi:10.1093/brain/awg127 · Cited by 51
Lymphocyte traffic control by chemokines: follicular B helper T cells
Moser, B., & Ebert, L. M. (2003) · Immunology Letters · doi:10.1016/s0165-2478(02)00233-x · Cited by 47
Maintenance of B lymphocyte‐related clones in the cerebrospinal fluid of multiple sclerosis patients
Colombo, M., Dono, M., Gazzola, P., et al. (2003) · European Journal of Immunology · doi:10.1002/eji.200324144 · Cited by 38
Flow cytometric analysis of chemokine receptor expression on cerebrospinal fluid leukocytes
Kivisäkk, P., Liu, Z., Trebst, C., Tucky, B. H., Wu, L., Stine, J. T., Mack, M., Rudick, R. A., Campbell, J. J., & Ransohoff, R. M. (2003) · Methods · doi:10.1016/s1046-2023(02)00355-9 · Cited by 30
Self-citationChemokine-based therapies for MS: how do we get there from here?
Kivisäkk, P., Trebst, C., Eckstein, D. J., Kerza-Kwiatecki, A. P., & Ransohoff, R. M. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02056-7 · Cited by 29
Self-citationTheil, D. J., Farina, C., & Meinl, E. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.019323 · Cited by 17
Self-citation
Cited by
Astrocytes are active players in cerebral innate immunity
Farina, C., Aloisi, F., & Meinl, E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.005 · Cited by 1,304
Self-citationThe blood-brain barrier in systemic inflammation
Varatharaj, A., & Galea, I. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.03.010 · Cited by 1,172
Astrocyte Crosstalk in CNS Inflammation
Linnerbauer, M., Wheeler, M. A., & Quintana, F. J. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.012 · Cited by 989
The therapeutic potential of neural stem cells
Martino, G., & Pluchino, S. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1908 · Cited by 744
Function and therapeutic value of astrocytes in neurological diseases
Lee, H.-G., Wheeler, M. A., & Quintana, F. J. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00390-x · Cited by 662
Metadata
- Authors
- Krumbholz, M., Theil, D., Cepok, S., Hemmer, B., Kivisäkk, P., Ransohoff, R. M., Hofbauer, M., Farina, C., Derfuss, T., Hartle, C., Newcombe, J., Hohlfeld, R., & Meinl, E.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-11-09
- Volume
- 129
- Issue
- 1
- Pages
- 200-211
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2124618760
- Cited by
- 561
- References
- 65
- FWCI
- 11.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.